NanoViricides Inc. (NNVC)

[loanranger]

That's one giant collection of BS, isn't it? A new NNVC record for its longest press release.

The very first paragraph (highlight added) should be enough to get the attention of the FDA, the SEC and the Class Action wolves:
"SHELTON, CT / ACCESSWIRE / August 9, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, provides further details on its rapid drug development strategy for Monkeypox virus."

NNVC hasn't developed A SINGLE highly effective antiviral therapy.